MP23-18 PRELIMINARY RESULTS OF A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT THERAPY IN MUSCLE-INVASIVE BLADDER CANCER. (May 2022)